IIQ (IIQ) News
Track canonical SquawkNews coverage tagged to IIQ, IIQ. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
INOVIQ Defines EXO-OC Commercialisation Path after Independent Review
INOVIQ ASX:IIQ has mapped a 12-to-18-month pathway to commercialise its EXO-OC ovarian cancer test as a US laboratory developed test (LDT), after an independent technical review supported its assessment of why the OC2200
NEWS | Sep 30, 2026, 12:18 AM UTC
L
Inoviq posts FY26 net loss after tax A$7.5 million
Inoviq reported FY26 net loss after tax of A$7.5 million.
EARNINGS | Aug 27, 2026, 01:23 AM UTC